article Open AccessTop 1% cited
Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study
Breast Cancer Research and Treatment · 2007 · Vol. 107(1) · pp. 103–111
A. Fournier✉Franco Berrino(Fondazione IRCCS Istituto Nazionale dei Tumori)Françoise Clavel‐Chapelon(Inserm)
Menopause: Health Impacts and TreatmentsEstrogen and related hormone effectsCancer Risks and FactorsDydrogesteroneMedicineBreast cancerEstrogenHormone replacement therapy (female-to-male)GynecologyOncologyInternal medicineRelative riskCohort
MeSH terms
AdultAgedBreast NeoplasmsDydrogesteroneEstrogensFemaleHumansMiddle AgedNeoplasm InvasivenessProgestinsProgesteroneRiskCohort StudiesPostmenopauseHormone Replacement Therapy
Citations
671
FWCI
22.54
field-weighted impact
References
29
Percentile
100%
vs. same field & year
Citations per year
References
Evaluating Medication Effects Outside of Clinical Trials: New-User Designs
American Journal of Epidemiology · 2003 · 1,601 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.